Federated Hermes’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.2M | Sell |
42,663
-29,159
| -41% | -$12.9M | 0.03% | 484 |
|
|
2026
Q1 | $32.1M | Sell |
71,822
-5,839
| -8% | -$2.72M | 0.05% | 364 |
|
|
2025
Q4 | $35.2M | Sell |
77,661
-108,908
| -58% | -$46.9M | 0.06% | 328 |
|
|
2025
Q3 | $73.1M | Sell |
186,569
-7,390
| -4% | -$3.09M | 0.13% | 189 |
|
|
2025
Q2 | $86.4M | Buy |
193,959
+23,726
| +14% | +$10.9M | 0.16% | 161 |
|
|
2025
Q1 | $82.5M | Sell |
170,233
-18,842
| -10% | -$8.78M | 0.18% | 144 |
|
|
2024
Q4 | $76.1M | Sell |
189,075
-2,864
| -1% | -$1.33M | 0.17% | 162 |
|
|
2024
Q3 | $89.3M | Sell |
191,939
-19,703
| -9% | -$9.46M | 0.2% | 134 |
|
|
2024
Q2 | $99.2M | Sell |
211,642
-273
| -0.1% | -$118K | 0.24% | 101 |
|
|
2024
Q1 | $88.6M | Buy |
211,915
+6,554
| +3% | +$2.77M | 0.2% | 129 |
|
|
2023
Q4 | $83.6M | Buy |
205,361
+12,542
| +7% | +$4.63M | 0.21% | 116 |
|
|
2023
Q3 | $67.1M | Buy |
192,819
+35,371
| +22% | +$12.4M | 0.18% | 139 |
|
|
2023
Q2 | $55.4M | Sell |
157,448
-12,211
| -7% | -$4.11M | 0.14% | 190 |
|
|
2023
Q1 | $53.5M | Buy |
169,659
+18,637
| +12% | +$5.59M | 0.13% | 183 |
|
|
2022
Q4 | $43.6M | Sell |
151,022
-5,368
| -3% | -$1.64M | 0.12% | 217 |
|
|
2022
Q3 | $45.3M | Sell |
156,390
-20,001
| -11% | -$5.75M | 0.13% | 200 |
|
|
2022
Q2 | $49.7M | Sell |
176,391
-63,757
| -27% | -$17.1M | 0.14% | 198 |
|
|
2022
Q1 | $62.7M | Sell |
240,148
-26,936
| -10% | -$6.39M | 0.14% | 187 |
|
|
2021
Q4 | $58.7M | Buy |
267,084
+16,440
| +7% | +$3.2M | 0.11% | 242 |
|
|
2021
Q3 | $45.5M | Buy |
250,644
+78,580
| +46% | +$15.3M | 0.09% | 295 |
|
|
2021
Q2 | $34.7M | Sell |
172,064
-98,665
| -36% | -$20.6M | 0.06% | 358 |
|
|
2021
Q1 | $58.2M | Sell |
270,729
-59,586
| -18% | -$13.1M | 0.11% | 236 |
|
|
2020
Q4 | $78.1M | Sell |
330,315
-30,941
| -9% | -$7.1M | 0.16% | 164 |
|
|
2020
Q3 | $98.3M | Sell |
361,256
-3,279
| -0.9% | -$905K | 0.23% | 106 |
|
|
2020
Q2 | $106M | Sell |
364,535
-34,322
| -9% | -$9.31M | 0.26% | 86 |
|
|
2020
Q1 | $94.9M | Sell |
398,857
-9,873
| -2% | -$2.26M | 0.28% | 77 |
|
|
2019
Q4 | $89.5M | Buy |
408,730
+27,454
| +7% | +$5.56M | 0.2% | 116 |
|
|
2019
Q3 | $64.6M | Buy |
381,276
+56,546
| +17% | +$10M | 0.16% | 146 |
|
|
2019
Q2 | $59.5M | Sell |
324,730
-3,680
| -1% | -$643K | 0.14% | 158 |
|
|
2019
Q1 | $60.4M | Buy |
328,410
+74,720
| +29% | +$13.8M | 0.15% | 149 |
|
|
2018
Q4 | $42M | Sell |
253,690
-47,947
| -16% | -$8.31M | 0.11% | 194 |
|
|
2018
Q3 | $58.1M | Sell |
301,637
-94,217
| -24% | -$16.8M | 0.14% | 175 |
|
|
2018
Q2 | $67.3M | Buy |
395,854
+154,169
| +64% | +$23.9M | 0.2% | 104 |
|
|
2018
Q1 | $39.4M | Buy |
241,685
+192,425
| +391% | +$31.4M | 0.11% | 156 |
|
|
2017
Q4 | $7.38M | Sell |
49,260
-2,026
| -4% | -$300K | 0.02% | 501 |
|
|
2017
Q3 | $7.8M | Buy |
51,286
+772
| +2% | +$116K | 0.02% | 451 |
|
|
2017
Q2 | $6.51M | Sell |
50,514
-10,259
| -17% | -$1.23M | 0.02% | 505 |
|
|
2017
Q1 | $6.64M | Sell |
60,773
-47,579
| -44% | -$4.19M | 0.02% | 507 |
|
|
2016
Q4 | $7.98M | Buy |
108,352
+3,800
| +4% | +$309K | 0.02% | 449 |
|
|
2016
Q3 | $9.12M | Sell |
104,552
-25,333
| -20% | -$2.39M | 0.03% | 448 |
|
|
2016
Q2 | $11.2M | Sell |
129,885
-78,121
| -38% | -$6.75M | 0.03% | 404 |
|
|
2016
Q1 | $16.5M | Sell |
208,006
-445,492
| -68% | -$40.3M | 0.05% | 305 |
|
|
2015
Q4 | $82.2M | Sell |
653,498
-32,720
| -5% | -$3.95M | 0.26% | 79 |
|
|
2015
Q3 | $71.5M | Buy |
686,218
+640,554
| +1,403% | +$82.3M | 0.23% | 80 |
|
|
2015
Q2 | $5.64M | Buy |
45,664
+110
| +0.2% | +$13.9K | 0.02% | 569 |
|
|
2015
Q1 | $5.37M | Buy |
45,554
+38,051
| +507% | +$4.56M | 0.02% | 589 |
|
|
2014
Q4 | $891K | Buy |
7,503
+2,650
| +55% | +$298K | ﹤0.01% | 1217 |
|
|
2014
Q3 | $545K | Buy |
4,853
+4
| +0.1% | +$381 | ﹤0.01% | 1330 |
|
|
2014
Q2 | $459K | Sell |
4,849
-3,148
| -39% | -$221K | ﹤0.01% | 1374 |
|
|
2014
Q1 | $566K | Sell |
7,997
-130,837
| -94% | -$10.4M | ﹤0.01% | 1313 |
|
|
2013
Q4 | $10.3M | Sell |
138,834
-101,648
| -42% | -$7.08M | 0.04% | 435 |
|
|
2013
Q3 | $18.2M | Buy |
240,482
+17,102
| +8% | +$1.36M | 0.07% | 246 |
|
|
2013
Q2 | $17.8M | Buy |
+223,380
| New | +$16.5M | 0.07% | 226 |
|
Other funds holding VRTX
Federated Hermes's VRTX Position: Q2 2026 in Review
Federated Hermes reduced its Vertex Pharmaceuticals (VRTX) stake by 41% in Q2 2026, selling an estimated $12.9M and leaving 42,663 shares worth $21.2M. The position accounts for 0.03% of the portfolio, ranked #484.
Federated Hermes first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $106M in Q2 2020. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Federated Hermes held 42,663 shares of Vertex Pharmaceuticals worth $21.2M as of Q2 2026.
- Federated Hermes sold 29,159 Vertex Pharmaceuticals shares in Q2 2026, an estimated $12.9M.
- Vertex Pharmaceuticals made up 0.03% of Federated Hermes's portfolio in Q2 2026, its #484 holding.
- Federated Hermes first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Federated Hermes's Vertex Pharmaceuticals position peaked at $106M in Q2 2020.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.